Sanofi, Mannkind launch inhaled insulin called Afrezza
Hoping to appeal to millions of needle-phobic Americans with diabetes, drugmakers Sanofi and Mannkind have just launched Afrezza, an insulin that's inhaled, rather than injected.
Feb 3, 2015
0
12